Giuseppe Villa

1.1k total citations
34 papers, 744 citations indexed

About

Giuseppe Villa is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Giuseppe Villa has authored 34 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 13 papers in Cardiology and Cardiovascular Medicine and 11 papers in Hematology. Recurrent topics in Giuseppe Villa's work include Dialysis and Renal Disease Management (11 papers), Blood Pressure and Hypertension Studies (11 papers) and Erythropoietin and Anemia Treatment (11 papers). Giuseppe Villa is often cited by papers focused on Dialysis and Renal Disease Management (11 papers), Blood Pressure and Hypertension Studies (11 papers) and Erythropoietin and Anemia Treatment (11 papers). Giuseppe Villa collaborates with scholars based in Italy, Spain and United States. Giuseppe Villa's co-authors include Ulrich Beyer, Francesco Locatelli, Delphine Oguey, Frank C. Dougherty, Steven Fishbane, Steven Zeig, Nathan W. Levin, John Moran, George M. Nassar and Giuseppe Mancia and has published in prestigious journals such as The Lancet, Diabetes Care and American Journal of Kidney Diseases.

In The Last Decade

Giuseppe Villa

34 papers receiving 704 citations

Peers

Countries citing papers authored by Giuseppe Villa

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Villa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Villa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Villa more than expected).

Fields of papers citing papers by Giuseppe Villa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Villa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Villa. The network helps show where Giuseppe Villa may publish in the future.

Co-authorship network of co-authors of Giuseppe Villa

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Villa. A scholar is included among the top collaborators of Giuseppe Villa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Villa. Giuseppe Villa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial 2016 ·Journal of Human Hypertension ·(unknown), Giuseppe Mancia, (unknown), Blas Gil Extremera, Peter Harvey, Andrew Lewin, Giuseppe Villa, Sverre E. Kjeldsen	3
2	Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile 2014 ·Journal of Hypertension ·Sverre E. Kjeldsen, Domenic Sica, Hermann Haller, (unknown), Blas Gil Extremera, Peter Harvey, (unknown), Andrew Lewin, Giuseppe Villa, Giuseppe Mancia	9
3	Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study) 2013 ·Trials ·Gianfranco Parati, Stefano Omboni, Angelo Compare, Enzo Grossi, Edward Callus, Achille Venco, Maurizio Destro, Giuseppe Villa, Paolo Palatini, Enrico Agabiti Rosei, Simonetta Scalvini, Stefano Taddei, Dario Manfellotto, Stefano Favale, (unknown), (unknown), (unknown)	32
4	Efficacy and safety of once-monthly continuous erythropoietin receptor activator in patients with chronic renal anemia 2013 ·Journal of Nephrology ·Francesco Locatelli, S. Mandolfo, (unknown), Giuseppe Villa, (unknown), Francesco Pizzarelli, Ferruccio Conte, Carlo Guastoni, (unknown), Alessandro Crotta	10
5	An Observational, Prospective, Open-Label, Multicentre Evaluation of Aliskiren in Treated, Uncontrolled Patients 2012 ·High Blood Pressure & Cardiovascular Prevention ·Giuliano Tocci, (unknown), (unknown), (unknown), (unknown), Antonino Granatelli, (unknown), Armando Magagna, (unknown), (unknown), Giuseppe Villa, Massimo Volpe	5
6	Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial 2012 ·Nephrology Dialysis Transplantation ·Francesco Locatelli, Paolo Altieri, (unknown), Giovanna Sau, (unknown), Luciano A. Pedrini, Carlo Basile, S. David, Mariano Feriani, (unknown), (unknown), D. Casu, (unknown), (unknown), (unknown), (unknown), (unknown), Giuseppe Villa, Biagio Di Iorio, Carmine Zoccali	29
7	Efficacy, Safety, and Tolerability of Aliskiren Monotherapy Administered With a Light Meal in Elderly Hypertensive Patients: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Response Evaluation Study 2011 ·The Journal of Clinical Pharmacology ·Giuseppe Villa, (unknown), Ghionul Ibram, Deborah Keefe	8
8	Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial 2010 ·Nephrology Dialysis Transplantation ·Fernando Carrera, Charmaine E. Lok, Angel de Francisco, Francesco Locatelli, Johannes F.E. Mann, Bernard Canaud, Peter G. Kerr, Iain C. Macdougall, Anatole Besarab, Giuseppe Villa, (unknown), Bruno Van Vlem, Shruti Jolly, Ulrich Beyer, Frank C. Dougherty, (unknown)	56
9	Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis 2009 ·Amyloid ·G. La Montagna, Sara Raimondi, Guido E. Moro, C. Uggetti, Annalisa Relini, Umberto Magrini, Gennaro Esposito, Sofia Giorgetti, (unknown), Mario Mosconi, (unknown), Giuseppe Villa, (unknown), Simona Donadei, Laura Obici, Giampaolo Merlini, Monica Stoppini, Vittorio Bellotti	3
10	C.E.R.A. once every 4 weeks in patients with chronic kidney disease not on dialysis: The ARCTOS extension study 2009 ·Hemodialysis International ·M. Kessler, Alberto Martínez‐Castelao, Kostas C. Siamopoulos, Giuseppe Villa, Bruce Spinowitz, Frank C. Dougherty, Ulrich Beyer	20
11	Efficacy and safety of once-weekly intravenous epoetin alfa in maintaining hemoglobin levels in hemodialysis patients 2008 ·Journal of Nephrology ·Francesco Locatelli, Giuseppe Villa, Piergiorgio Messa, (unknown), Giuseppe Cannella, (unknown), A Naso, (unknown), Marco Formica, Luigi Lombardi, (unknown), (unknown)	8
12	Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study 2008 ·Nephrology Dialysis Transplantation ·Bernard Canaud, G. Mingardi, J. Braun, Pedro Aljama, Peter G. Kerr, Francesco Locatelli, Giuseppe Villa, Bruno Van Vlem, Alan W. McMahon, Cécile Kerloëguen, Ulrich Beyer, (unknown)	52
13	Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA) 2007 ·The Lancet ·Nathan W. Levin, Steven Fishbane, (unknown), Steven Zeig, George M. Nassar, John Moran, Giuseppe Villa, Ulrich Beyer, Delphine Oguey	114
14	Prevention of dialysis hypotension episodes using fuzzy logic control system 2007 ·Nephrology Dialysis Transplantation ·Elena Mancini, (unknown), (unknown), Domenico Gabrielli, C Cascone, Ferruccio Conte, (unknown), (unknown), Alessandro Antonelli, Giuseppe Villa, Antonio Dal Canton, L Cagnoli, Filippo Aucella, (unknown), E. Gaggiotti, Giacinto Triolo, (unknown), Aurelia Santoro	37
15	Effect of a continuous erythropoietin receptor activator (C.E.R.A.) on stable haemoglobin in patients with CKD on dialysis: once monthly administration 2007 ·Current Medical Research and Opinion ·Francesco Locatelli, Giuseppe Villa, Ángel Francisco, A Albertazzi, Horacio J. Adrogué, Frank C. Dougherty, Ulrich Beyer, (unknown)	51
16	Once-weekly compared with three-times-weekly subcutaneous epoetin β: Results from a randomized, multicenter, therapeutic-equivalence study 2002 ·American Journal of Kidney Diseases ·Francesco Locatelli, C. A. Baldamus, Giuseppe Villa, (unknown), Ángel L.M. de Francisco	51
17	An ambulatory blood pressure monitoring study of the comparative antihypertensive efficacy of two angiotensin II receptor antagonists, irbesartan and valsartan 2002 ·Blood Pressure Monitoring ·Giuseppe Mancia, (unknown), Peter van Rossum, Giuseppe Villa, (unknown)	47
18	Pharmacokinetics of nicorandil in patients with normal and impaired renal function 1992 ·European Journal of Clinical Pharmacology ·(unknown), Giuseppe Villa, Mario Regazzi, (unknown), S Segagni, R Rondanelli, (unknown)	15
19	Pharmacokinetics of teicoplanin in the elderly 1988 ·Journal of Antimicrobial Chemotherapy ·(unknown), Giuseppe Villa, (unknown), (unknown), (unknown), (unknown)	14
20	Cadralazine, a new vasodilator, in addition to a beta-blocker for long-term treatment of hypertension. 1985 ·PubMed ·(unknown), Giuseppe Villa, S Segagni, V. Piazza, (unknown), Maria Francesca Romano, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact